Modulation of striatal dopamine release in cerebral ischemia byL-arginine |
| |
Authors: | Maria Spatz Yoshihide Yasuma Alois Strasser Nobutoshi Kawai Danica Stanimirovic Richard McCarron |
| |
Institution: | (1) Stroke Brach, National Institute of Neurological Disorders and Stroke National Institutes of Health, Bethesda, Maryland;(2) Neurocytobiology Section, Stroke Branch, NINDS, NIH, Building 36, Room 4A03, 20892 Bethesda, Maryland |
| |
Abstract: | The effect ofL-arginine, the precursor of nitric oxide, on ischemic dopamine release from the striatum was investigated in Mongolian gerbils subjected to bilateral carotid artery occlusion (15 min) alone or with reflow (2 h). Dopamine and its metabolites were measured in the striatal extracellular space dialysate after continuous perfusion (2 l/min) of artificial extracellular fluid in the presence or absence of 15 mmol/literL- orD-arginine or 1 mmol/liter nitro-L-arginine.L-Arginine but notD-arginine increased the striatal content of dopamine in pre- and postischemia whereas it lowered the levels of dopamine and 3-methoxytyramine induced by ischemia. In contrast, nitro-L-arginine reduced the preischemic levels of dopamine and 3,4-dihydroxyphenyl-acetic acid, and had no effect on the ischemic release of dopamine. These findings indicate thatL-arginine stereospecifically modified the ischemic release and metabolism of dopamine. The data also suggest that the basal level of nitric oxide is not involved in dopamine release during ischemia but may participate in regulating dopamine release under physiological conditions.Presented in part at the 19th International Joint Conference on Stroke and Cerebral Circulation, San Diego, California, February 17–19, 1994. |
| |
Keywords: | Brain ischemia dopamine release L-arginine" target="_blank">L-arginine L-arginine" target="_blank">nitro-L-arginine |
本文献已被 SpringerLink 等数据库收录! |
|